TrialDiabetologia2016

Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment.

Paola Fioretto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.